Asieris(SH:688176) Xin Lang Cai Jing·2025-09-09 07:23Group 1 - The core viewpoint of the news is that Yahui Pharmaceutical experienced a decline in stock price, with a drop of 5.04% to 11.49 CNY per share, and a trading volume of 209 million CNY, resulting in a total market capitalization of 6.563 billion CNY [1] - Yahui Pharmaceutical, established on March 16, 2010, and listed on January 7, 2022, focuses on the research, production, and sales of innovative drugs, with 96.34% of its revenue coming from anti-tumor products [1] Group 2 - Among the top ten circulating shareholders of Yahui Pharmaceutical, Penghua Fund holds a significant position, with its Penghua Medical Technology Stock A (001230) increasing its holdings by 891,300 shares in the second quarter, totaling 6.5441 million shares, which represents 1.73% of the circulating shares [2] - The latest scale of Penghua Medical Technology Stock A is 1.987 billion CNY, with a year-to-date return of 95.32%, ranking 18 out of 4222 in its category, and a one-year return of 111.48%, ranking 146 out of 3798 [2]